CORT
Corcept Therapeutics Incorporated$69.07-3.90 (-5.35%)Prev Close$72.94·MCap$7.98B·P/E209.69·Vol664.1K·Yield—
▲
Buys (12M)
1
$3.31M
▼
Sells (12M)
57
$134.82M
◆
Net Activity
Net Seller
$131.50M
●
Active Insiders
13
last 12 mo
Over the past 12 months, insider activity at Corcept Therapeutics Incorporated (CORT) has been dominated by selling, with 1 insider purchase totaling $3.31M and 57 insider sales totaling $134.82M. The most recent insider transaction was by Swisher Daniel N JR (director), who sold $111.1K worth of shares on Nov 13, 2026. Corcept Therapeutics Incorporated operates in the Healthcare sector, within the Medical - Pharmaceuticals industry, with a market cap of $7.98B.
CORT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Swisher Daniel N JR | director | Sell | 1,500 | $74.07 | $111.1K | 0Exit |
| Nov 4, 2026 | Maduck Sean | other: See Remarks | Sell | 25,000 | $81.85 | $2.05M | 14,480-63% |
| Nov 4, 2026 | Vieira Roberto Wandenkolk | officer: President, Oncology | Sell | 8,333 | $80.89 | $674.1K | 5,622-60% |
| Oct 16, 2026 | WILSON JAMES N | director | Sell | 10,000 | $114.81 | $1.15M | 1,057,889 |
| Oct 5, 2026 | Vieira Roberto Wandenkolk | officer: President, Oncology | Sell | 8,333 | $116.10 | $967.4K | 11,179-43% |
| Oct 5, 2026 | Lyon Joseph Douglas | officer: See Remarks | Sell | 10,000 | $116.07 | $1.16M | 10,427-49% |
| Oct 5, 2026 | Maduck Sean | officer: See Remarks | Sell | 25,000 | $116.26 | $2.91M | 18,682-57% |
| Sep 18, 2026 | Vieira Roberto Wandenkolk | officer: President, Oncology | Sell | 296 | $100.82 | $29.8K | 3,946 |
| Sep 16, 2026 | Lyon Joseph Douglas | officer: See Remarks | Sell | 10,000 | $113.49 | $1.13M | 7,871-56% |
| Sep 16, 2026 | WILSON JAMES N | director | Sell | 10,000 | $110.69 | $1.11M | 1,067,743 |
| Sep 3, 2026 | Vieira Roberto Wandenkolk | officer: President, Oncology | Sell | 58,333 | $110.76 | $6.46M | 38,975-60% |
| Sep 3, 2026 | Maduck Sean | officer: See Remarks | Sell | 25,000 | $114.43 | $2.86M | 23,025-52% |
| Aug 28, 2026 | Park Kimberly | director | Sell | 26,685 | $122.55 | $3.27M | 0Exit |
| Aug 27, 2026 | Maduck Sean | officer: See Remarks | Sell | 30,955 | $125.58 | $3.89M | 15,625-66% |
| Aug 20, 2026 | MAHONEY DAVID L | director | Sell | 103,606 | $118.25 | $12.25M | 1,232,161 |
| Aug 18, 2026 | Robb Gary Charles | officer: Chief Business Officer | Sell | 10,000 | $116.26 | $1.16M | 39,716 |
| Aug 18, 2026 | WILSON JAMES N | director | Sell | 10,000 | $111.43 | $1.11M | 1,081,490 |
| Aug 18, 2026 | Maduck Sean | officer: See Remarks | Sell | 3,664 | $114.49 | $419.5K | 9,755-27% |
| Aug 12, 2026 | Guyer William | officer: Chief Development Officer | Sell | 16,300 | $113.43 | $1.85M | 8,755-65% |
| Aug 12, 2026 | Maduck Sean | officer: See Remarks | Sell | 1,031 | $114.52 | $118.1K | 9,755 |
| Aug 6, 2026 | Guyer William | officer: Chief Development Officer | Sell | 3,700 | $113.12 | $418.6K | 3,985-48% |
| Aug 5, 2026 | Maduck Sean | officer: See Remarks | Sell | 20,305 | $114.70 | $2.33M | 9,755-68% |
| Aug 5, 2026 | Lyon Joseph Douglas | officer: See Remarks | Sell | 1,540 | $114.16 | $175.8K | 5,495 |
| Aug 3, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 80,000 | $114.71 | $9.18M | 91,930-47% |
| Jul 17, 2026 | WILSON JAMES N | director | Sell | 10,000 | $88.30 | $883.0K | 1,093,464 |
| Jul 17, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 40,000 | $87.71 | $3.51M | 48,211-45% |
| Jul 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $93.13 | $1.86M | 4,937-80% |
| Jul 6, 2026 | Maduck Sean | officer: See Remarks | Sell | 25,000 | $88.35 | $2.21M | 23,731-51% |
| Jun 18, 2026 | MAHONEY DAVID L | director | Sell | 20,000 | $84.53 | $1.69M | 26,147-43% |
| Jun 18, 2026 | WILSON JAMES N | director | Sell | 10,000 | $83.20 | $832.0K | 1,100,366 |
| Jun 17, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 40,000 | $81.15 | $3.25M | 46,696-46% |
| Jun 4, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $70.60 | $1.41M | 3,985-83% |
| Jun 3, 2026 | Maduck Sean | officer: See Remarks | Sell | 25,000 | $70.21 | $1.76M | 12,908-66% |
| Jun 3, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 40,000 | $70.00 | $2.80M | 15,257-72% |
| Jun 2, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 12,837 | $69.74 | $895.3K | 2,565,489 |
| May 29, 2026 | Lyon Joseph Douglas | officer: See Remarks | Sell | 5,000 | $65.00 | $325.0K | 6,230-45% |
| May 29, 2026 | Maduck Sean | officer: See Remarks | Sell | 75,000 | $65.59 | $4.92M | 29,402-72% |
| May 7, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $51.83 | $1.04M | 2,231-90% |
| May 5, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 40,000 | $50.10 | $2.00M | 2,878,326 |
| Apr 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.97 | $819.4K | 2,231-90% |
| Mar 27, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 26,198 | $50.07 | $1.31M | 2,918,326 |
| Mar 24, 2026 | Guyer William | officer: Chief Development Officer | Sell | 11,767 | $36.01 | $423.7K | 2,231-84% |
| Mar 19, 2026 | BAKER G LEONARD JR | director | Buy | 100,000 | $33.14 | $3.31M | 1,146,631 |
| Mar 6, 2026 | Guyer William | officer: Chief Development Officer | Sell | 8,233 | $35.99 | $296.3K | 2,231-79% |
| Feb 9, 2026 | Hunt Hazel | Chief Scientific Officer | Sell | 77,968 | $41.31 | $3.22M | 0 |
| Feb 5, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 1,235-94% |
| Feb 3, 2026 | Guyer William | Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 0 |
| Jan 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 1,235-94% |
| Jan 6, 2026 | Guyer William | Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 0 |
| Dec 24, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 306,846 | $83.59 | $25.65M | 0 |
Showing 1–50 of 224
1 / 5
CORT Insider Buying Activity
The following table shows recent insider purchases of Corcept Therapeutics Incorporated (CORT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | BAKER G LEONARD JR | director | Buy | 100,000 | $33.14 | $3.31M | 1,146,631 |
CORT Insider Selling Activity
The following table shows recent insider sales of Corcept Therapeutics Incorporated (CORT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Swisher Daniel N JR | director | Sell | 1,500 | $74.07 | $111.1K | 0Exit |
| Nov 4, 2026 | Maduck Sean | other: See Remarks | Sell | 25,000 | $81.85 | $2.05M | 14,480-63% |
| Nov 4, 2026 | Vieira Roberto Wandenkolk | officer: President, Oncology | Sell | 8,333 | $80.89 | $674.1K | 5,622-60% |
| Oct 16, 2026 | WILSON JAMES N | director | Sell | 10,000 | $114.81 | $1.15M | 1,057,889 |
| Oct 5, 2026 | Vieira Roberto Wandenkolk | officer: President, Oncology | Sell | 8,333 | $116.10 | $967.4K | 11,179-43% |
| Oct 5, 2026 | Lyon Joseph Douglas | officer: See Remarks | Sell | 10,000 | $116.07 | $1.16M | 10,427-49% |
| Oct 5, 2026 | Maduck Sean | officer: See Remarks | Sell | 25,000 | $116.26 | $2.91M | 18,682-57% |
| Sep 18, 2026 | Vieira Roberto Wandenkolk | officer: President, Oncology | Sell | 296 | $100.82 | $29.8K | 3,946 |
| Sep 16, 2026 | Lyon Joseph Douglas | officer: See Remarks | Sell | 10,000 | $113.49 | $1.13M | 7,871-56% |
| Sep 16, 2026 | WILSON JAMES N | director | Sell | 10,000 | $110.69 | $1.11M | 1,067,743 |
| Sep 3, 2026 | Vieira Roberto Wandenkolk | officer: President, Oncology | Sell | 58,333 | $110.76 | $6.46M | 38,975-60% |
| Sep 3, 2026 | Maduck Sean | officer: See Remarks | Sell | 25,000 | $114.43 | $2.86M | 23,025-52% |
| Aug 28, 2026 | Park Kimberly | director | Sell | 26,685 | $122.55 | $3.27M | 0Exit |
| Aug 27, 2026 | Maduck Sean | officer: See Remarks | Sell | 30,955 | $125.58 | $3.89M | 15,625-66% |
| Aug 20, 2026 | MAHONEY DAVID L | director | Sell | 103,606 | $118.25 | $12.25M | 1,232,161 |
| Aug 18, 2026 | Robb Gary Charles | officer: Chief Business Officer | Sell | 10,000 | $116.26 | $1.16M | 39,716 |
| Aug 18, 2026 | WILSON JAMES N | director | Sell | 10,000 | $111.43 | $1.11M | 1,081,490 |
| Aug 18, 2026 | Maduck Sean | officer: See Remarks | Sell | 3,664 | $114.49 | $419.5K | 9,755-27% |
| Aug 12, 2026 | Guyer William | officer: Chief Development Officer | Sell | 16,300 | $113.43 | $1.85M | 8,755-65% |
| Aug 12, 2026 | Maduck Sean | officer: See Remarks | Sell | 1,031 | $114.52 | $118.1K | 9,755 |
| Aug 6, 2026 | Guyer William | officer: Chief Development Officer | Sell | 3,700 | $113.12 | $418.6K | 3,985-48% |
| Aug 5, 2026 | Maduck Sean | officer: See Remarks | Sell | 20,305 | $114.70 | $2.33M | 9,755-68% |
| Aug 5, 2026 | Lyon Joseph Douglas | officer: See Remarks | Sell | 1,540 | $114.16 | $175.8K | 5,495 |
| Aug 3, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 80,000 | $114.71 | $9.18M | 91,930-47% |
| Jul 17, 2026 | WILSON JAMES N | director | Sell | 10,000 | $88.30 | $883.0K | 1,093,464 |
| Jul 17, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 40,000 | $87.71 | $3.51M | 48,211-45% |
| Jul 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $93.13 | $1.86M | 4,937-80% |
| Jul 6, 2026 | Maduck Sean | officer: See Remarks | Sell | 25,000 | $88.35 | $2.21M | 23,731-51% |
| Jun 18, 2026 | MAHONEY DAVID L | director | Sell | 20,000 | $84.53 | $1.69M | 26,147-43% |
| Jun 18, 2026 | WILSON JAMES N | director | Sell | 10,000 | $83.20 | $832.0K | 1,100,366 |
| Jun 17, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 40,000 | $81.15 | $3.25M | 46,696-46% |
| Jun 4, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $70.60 | $1.41M | 3,985-83% |
| Jun 3, 2026 | Maduck Sean | officer: See Remarks | Sell | 25,000 | $70.21 | $1.76M | 12,908-66% |
| Jun 3, 2026 | Mokari Atabak | officer: Chief Financial Officer | Sell | 40,000 | $70.00 | $2.80M | 15,257-72% |
| Jun 2, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 12,837 | $69.74 | $895.3K | 2,565,489 |
| May 29, 2026 | Lyon Joseph Douglas | officer: See Remarks | Sell | 5,000 | $65.00 | $325.0K | 6,230-45% |
| May 29, 2026 | Maduck Sean | officer: See Remarks | Sell | 75,000 | $65.59 | $4.92M | 29,402-72% |
| May 7, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $51.83 | $1.04M | 2,231-90% |
| May 5, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 40,000 | $50.10 | $2.00M | 2,878,326 |
| Apr 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.97 | $819.4K | 2,231-90% |
| Mar 27, 2026 | BELANOFF JOSEPH K | director, officer: Chief Executive Officer | Sell | 26,198 | $50.07 | $1.31M | 2,918,326 |
| Mar 24, 2026 | Guyer William | officer: Chief Development Officer | Sell | 11,767 | $36.01 | $423.7K | 2,231-84% |
| Mar 6, 2026 | Guyer William | officer: Chief Development Officer | Sell | 8,233 | $35.99 | $296.3K | 2,231-79% |
| Feb 9, 2026 | Hunt Hazel | Chief Scientific Officer | Sell | 77,968 | $41.31 | $3.22M | 0 |
| Feb 5, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 1,235-94% |
| Feb 3, 2026 | Guyer William | Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 0 |
| Jan 8, 2026 | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 1,235-94% |
| Jan 6, 2026 | Guyer William | Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 0 |
| Dec 24, 2025 | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 306,846 | $83.59 | $25.65M | 0 |
CORT Insiders
Similar Stocks to CORT
LLY
Eli Lilly and Company
$1430.73-0.91%
$1.35T
JNJ
Johnson & Johnson
$282.90-1.01%
$675.03B
ABBV
AbbVie Inc.
$294.54-0.22%
$521.41B
UNH
UnitedHealth Group Incorporated
$410.34+0.70%
$361.04B
TMO
Thermo Fisher Scientific Inc.
$689.69-1.52%
$265.92B
GILD
Gilead Sciences, Inc.
$167.25-0.55%
$210.52B
DHR
Danaher Corporation
$230.28-1.28%
$165.55B
ISRG
Intuitive Surgical, Inc.
$437.07-1.43%
$155.83B